Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease Akebia Therapeutics, Inc. (NASDAQ:AKBA), a ...
Have a look here: http://amsterdamklezmerband.com/band/ Mix a dose of klezmer with a pinch of ska, add a shot of Balkan and a smidchen of Gypsy, top it all off with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results